Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Dermatologic 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Multiple Myeloma 1Melanoma 1Lymphoma, Mantle-Cell 1Lymphoma, Large B-Cell, Diffuse 1Lymphoma, Follicular 1Lymphoma 1Leukemia, Myeloid, Acute 1Leukemia, Lymphocytic, Chronic, B-Cell 1Hodgkin Disease 1Hematologic Neoplasms 1Glioblastoma 1Diffuse Intrinsic Pontine Glioma 1Advanced Cutaneous Melanoma of the Extremity 1

Interventions

CBLC137 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Interventional × Advanced Cutaneous Melanoma of the Extremity × CBLC137 × Clear all
NCT03727789 2024-03-27

CBL0137 in Treating Patients With Advanced Extremity Melanoma or Sarcoma

Roswell Park Cancer Institute

Phase 1 Terminated
7 enrolled
DermatologicSarcoma

Advanced Cutaneous Melanoma of the Extremity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡